Skip to content Print

Medix Biochemica in brief

Established in 1985
Owned by Minerva Foundation
Employs over 90 persons

Read about history and backround

Medix Biochemica - 30 years of excellence

Medix Biochemica is a Finnish biotechnology company that develops, produces and markets monoclonal antibodies for IVD industry and diagnostic rapid tests for human healthcare worldwide.

Business activities

MedixMAB monoclonal antibodies for IVD applications - industrial scale manufacturing
MedixMAB Manufacturing services
MedixMAB by Design recombinant antibodies
Actim rapid tests for human healthcare - particularly for pregnancy monitoring

Core competencies

Flexible production - from milligrams to hundreds of grams
Constant quality - from batch to batch
Quick and accurate deliveries globally
Competetive pricing

Back to top